tenofovir disoproxil fumarate
- Product NDC
- 69025-100
- 11-digit product format
- 690250100
- Labeler code
- 69025
- Product ID
- 69025-100_e23a06d9-5379-462e-9cb0-9462086c5f3d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tenofovir disoproxil fumarate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AIZANT DRUG RESEARCH SOLUTIONS PVT LTD
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2018-01-26
- Marketing end
- 0000-00-00
- Substance
- TENOFOVIR DISOPROXIL FUMARATE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69025-100-01 | tenofovir disoproxil fumarate | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69025-100 | TENOFOVIR DISOPROXIL FUMARATE TABLET, FILM COATED [AIZANT DRUG RESEARCH SOLUTIONS PVT LTD] | 1 | Legacy NDC, 1 package rows | 20180126_79b774fe-abcd-47b4-943b-e82fc87bd6df.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 69025-100-01 | 69025010001 | 30 in 1 BOTTLE | Historical |